Jennifer Lettsome
Adult Health · Los Angeles, CANPI 1316397896
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 232 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Gilead at 52.3% of the total. Among adult health clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 232 payments — averaging $25.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$3K
- Viiv Healthcare Company$1K
- Merck$562
- GSK$200
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$142
- Abbott$134
- plus $687 from 16 others
What the payments were for
- Food & beverage$5,987100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 122 | $3,129 |
| Viiv Healthcare Company | 43 | $1,132 |
| Merck | 28 | $562 |
| GSK | 9 | $200 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $142 |
| Abbott | 1 | $134 |
| AbbVie | 5 | $112 |
| Alnylam Pharmaceuticals Inc. | 1 | $99 |
| Neurocrine Biosciences, Inc. | 2 | $77 |
| Novo Nordisk | 4 | $69 |
| Lilly USA, LLC | 2 | $55 |
| Dynavax Technologies Corporation | 2 | $41 |
| Johnson & Johnson | 2 | $40 |
| Napo Pharmaceuticals Inc | 2 | $38 |
| EMD Serono, Inc. | 1 | $24 |
| Theratechnologies Inc. | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Pfizer | 1 | $20 |
| Ionis Pharmaceuticals, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Exact Sciences | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$142
- FREESTYLE LIBRE 3$134
How this compares
$5,987 in reported general payments places this provider in the 90th percentile of 785 adult health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 29 | $115,037 |
| TrulicityDulaglutide | 42 | $44,332 |
| JardianceEmpagliflozin | 32 | $36,964 |
| OzempicSemaglutide | 19 | $18,453 |
| JanuviaSitagliptin Phosphate | 14 | $15,586 |
| Amlodipine-Valsartan-HctzAmlodipine/Valsartan/Hcthiazid | 26 | $15,556 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $8,696 |
| EliquisApixaban | 13 | $7,297 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $4,063 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $3,022 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 52 | $987 |
| Amlodipine-OlmesartanAmlodipine Bes/Olmesartan Med | 26 | $894 |
| Atorvastatin Calcium | 171 | $885 |
| Amlodipine-ValsartanAmlodipine Besylate/Valsartan | 21 | $868 |
| Omeprazole | 73 | $422 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy | $3,129 | $115,03729 claims |
| Lilly USA, LLCTrulicity | $55 | $44,33242 claims |
| Boehringer IngelheimJardiance | $17 | $36,96432 claims |
| Novo NordiskOzempic | $69 | $18,45319 claims |
| MerckJanuvia | $562 | $15,58614 claims |
| PfizerEliquis | $20 | $7,29713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 785 adult health providers in California.
Other adult health in Los Angeles
- Karolina FaysmanLos Angeles$1.1M
- Linda BuckLos Angeles$170K
- Lisa HinemanLos Angeles$29K
- Tammy HarperLos Angeles$11K
- Melissa LeeLos Angeles$5K
- Jamie YoonLos Angeles$5K
- Naomi PesynaAnaheim$141K
- Stacy GrissenEncinitas$82K
- Kimberly PodsadaSan Diego$78K
- Brenda PatrickSan Leandro$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.